Fresenius Medical Care
Financials
2023 Annual Revenue
€19.45 Billion
2023 Annual Gross Profit
€4.93 Billion
2023 Annual Net Income
€732 Million
2023 Total Assets
€33.93 Billion
2023 Number of Locations
3,925
Credit Rating
Moody's Rated: Investment Grade Baa3 (Long-Term)
Fresenius Medical Care
Fresenius Medical Care (NYSE: FMS) provides dialysis-related products, inpatient/outpatient care, and services such as engineering to hospitals and related facilities. Their facilities routinely provide medically necessary renal care to hundreds of thousands of patients with chronic kidney failure.